An integrative multi-platform analysis for discovering biomarkers of osteosarcoma

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Li, Guodong ^a,b   Zhang, Wenjuan ^c   Zeng, Huazong ^d   Chen, Lei ^e   Wang, Wenjing ^f   Liu, Jilong ^d   Zhang, Zhiyu ^a   Cai, Zhengdong ^a,b  

^a TONGJI UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d Shanghai Foundation Engineering Co Ltd   (China)

^e SECOND MILITARY MEDICAL UNIVERSITY   (China)

^f SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C1; IMMUNOGLOBULIN HEAVY CHAIN; TUMOR MARKER; PLASMA PROTEIN;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EARLY DIAGNOSIS; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE MAPPING; HUMAN; HUMAN CELL; MARKER GENE; MICROARRAY ANALYSIS; MOLECULAR WEIGHT; OSTEOBLAST; OSTEOSARCOMA; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; UPREGULATION; WESTERN BLOTTING; CASE CONTROL STUDY; CHEMISTRY; DNA MICROARRAY; FEMALE; GENETICS; MALE; MASS SPECTROMETRY; METABOLISM; TUMOR CELL LINE;

ADOLESCENT; ADULT; BLOOD PROTEINS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CHILD; CYTOCHROMES C1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOSARCOMA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 67449135223     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-150     Document Type: Article

References (20)

1. Deng X Geng H Bastola DR Ali HH Link test-A statistical method for finding prostate cancer biomarkers Comput Biol Chem 2006, 30:425-433. 1941704 17126079 10.1016/j.compbiolchem.2006.09.002
2. Sztán M Pápai Z Szendrôi M Looij M Oláh E Allelic losses from chromosome 17 in human osteosarcoma Pathol Oncol Res 1997, 3:115-120. 10.1007/BF02907805 11173637
3. Dahlin DC Pathology of osteosarcoma Clin Orthop 1975, 111:23-32. 10.1097/ 00003086-197509000-00004 168999
4. Enneking WF Spanier SS Goodman MA Current concepts review. The surgical staging of musculoskeletal staging of musculoskeletal sarcoma J Bone Joint Surg Am 1980, 62(6):1027-30. 7000786
5. Jin S Shen JN Guo QC Zhou JG Wang J Huang G Zou CY Yin JQ LIu SJ Liu W Li MT Wang LN 2-D DIGE and MALDI-TOF-MS analysis of the serum proteome in human osteosarcoma PROTEOMICS - Clin Appl 2007, 1:272-285. 10.1002/ prca.200600869
6. Philip T Iliescu C Demaille MC Pacquement H Gentet JC Krakowski I Soler-Michel P Thiesse P Chauvin F Blay JY Brunat-Mentigny M High-dose methotrexate and HELP [Holoxan (ifosfamide), Eldesine (vindesine), platinum] - doxorubicin in non-metastatic osteosarcoma of the extremity: A French multicentre pilot study Ann Oncol 1999, 10:1065-1071. 10.1023/ A:1008395126800 10572604
7. Bacci G Mercuri M Briccoli A Ferrari S Bertoni F Donati D Monti C Zanoni A Forni C Manfrini M Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions Cancer 1997, 15:245-254. 10.1002/ (SICI)1097-0142(19970115)79:2<245::AID-CNCR7>3.0.CO;2-J
8. Li Y Dang TA Shen J Perlaky L Hicks J Murray J Meyer W Chintagumpala M Lau CC Man TK Identification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondroma Proteomics 2006, 6:3426-3435. 10.1002/pmic.200500472 16673437
9. Diamandis EP Mass spectrometry as a diagnostic and a cancer biomarker discovery tool Mol Cell Proteom 2004, 3:367-378. 10.1074/ mcp.R400007-MCP200
10. Sorace JM Zhan M A data review and re-assessment of ovarian cancer serum proteomic profiling BMC Bioinformatics 2003, 4:24. 165662 12795817 10.1186/1471-2105-4-24
11. Baggerly KA Morris JS Coombes KR Reproducibility of SELDI mass spectrometry patterns in serum: Comparing proteomic data sets from different experiments Bioinformatics 2004, 20:777-785. 10.1093/ bioinformatics/btg484 14751995
12. Pisitkun T Johnstone R Knepper MA Discovery of urinary biomarkers Mol Cell Proteomics 2006, 5:1760-1771. 10.1074/mcp.R600004-MCP200 16837576
13. Whelan LC Power KA McDowell DT Kennedy PJ Gallagher WM Applications of Seldi Technology In Oncology J Cell Mol Med 2008, 12(5A):1535-47. 10.1111/j.1582-4934.2008.00250.x 18266982
14. Benjamini Y Drai D Elmer G Kafkafi N Golani I Controlling thefalse discovery rate in behavior genetics research Behav Brain Res 2001, 125:279-284. 10.1016/S0166-4328(01)00297-2 11682119
15. Hosack DA Dennis G Jr Sherman BT Lane HC Lempicki RA Identifying biological themes within lists of genes with EASE Genome Biol 2003, 4(10):R70. 328459 14519205 10.1186/gb-2003-4-10-r70
16. Bairoch A Apweiler R The SWISS-PROT protein sequence database: Its relevance to human molecular medical research J Mol Med 1997, 75:312-316. 9181472
17. Gasteiger E Jung E Bairoch A SWISS-PROT: Connecting biological knowledge via a protein database Curr Issues Mol Biol 2001, 3:47-55. 11488411
18. Boeckmann B Bairoch A Apweiler R Blatter MC Estreicher A Gasteiger E Martin MJ Michoud K O'Donovan C Phan I Pilbout S Schneider M The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003 Nucleic Acids Res 2003, 31:365-370. 165542 12520024 10.1093/nar/gkg095
19. UniProt Consortium The Universal Protein Resource (UniProt) 2009 Nucleic Acids Res 2009, 37(Database):D169-74. 10.1093/nar/gkn664 18836194
20. Tafani M Karpinich NO Hurster KA Pastorino JG Schneider T Russo MA Farber JL Cytochrome c release upon Fas receptor activation depends on translocation of full-length bid and the induction of the mitochondrial permeability transition J Biol Chem 2002, 277:10073-10082. 10.1074/ jbc.M111350200 11790791